Suppr超能文献

对轻型黏多糖贮积症II型患者情绪调适、生活质量及适应功能的纵向研究。

A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II.

作者信息

Shapiro Elsa G, Rudser Kyle, Ahmed Alia, Steiner Robert D, Delaney Kathleen A, Yund Brianna, King Kelly, Kunin-Batson Alicia, Eisengart Julie, Whitley Chester B

机构信息

Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.

Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.

出版信息

Mol Genet Metab Rep. 2016 Apr 1;7:32-9. doi: 10.1016/j.ymgmr.2016.03.005. eCollection 2016 Jun.

Abstract

OBJECTIVES

The behavioral, adaptive and quality of life characteristics of attenuated mucopolysaccharidosis type II (MPS II) have not been well studied. Understanding changes over time in the attenuated phenotype may assist in helping achieve better outcomes in long-term function. This longitudinal study investigates these outcomes in relation to age, somatic disease burden, and IQ. Specifically, somatic disease burden is a major challenge for these patients, even with treatment with enzyme replacement therapy.

METHODS

15 patients, 10 between ages 6 and < 12 and 5 between ages ≥ 12 and 18, were selected who had at least 2 yearly visits. The occurrence of physical signs, the Physical Symptom Score, and IQ in these two groups was studied as well as the longitudinal association of age with standardized measures of quality of life, adaptive function, and behavioral symptoms as rated by parents and the child's self-report. Slopes by age across and within patients were calculated for these measures.

RESULTS

All but one child had hearing loss, most had joint contractures and short stature. Somatic disease burden increased with age. IQ, although normal for most, also improved with age in those under 12 years of age. Physical quality of life decreased while psychosocial quality of life increased with age. Although other adaptive skills were in the broad average range, daily living skills were low at baseline relative to normative data and decreased over time. Behavior ratings indicated improvement in attention and hyperactivity over time. No patient had severe psychopathology, but older children reported an increasing sense of inadequacy and low self-esteem on self-report, presumably due to increasing awareness of differences from peers over time.

CONCLUSIONS

Attenuated MPS II patients have increasing somatic disease burden and poor physical quality of life as they develop as well as decreasing self-esteem and sense of adequacy. Psychosocial quality of life, adaptive skills, and attention improve. Recognition of and intervention around these issues will be beneficial to MPS II attenuated patients who have the resources to use such assistance to improve their long-term outcomes.

摘要

目的

对于症状较轻的黏多糖贮积症II型(MPS II)患者的行为、适应能力和生活质量特征,目前尚未得到充分研究。了解症状较轻的表型随时间的变化,可能有助于实现更好的长期功能预后。这项纵向研究调查了这些预后与年龄、躯体疾病负担和智商之间的关系。具体而言,即使接受酶替代疗法治疗,躯体疾病负担仍是这些患者面临的一项重大挑战。

方法

选取了15名患者,其中10名年龄在6岁至12岁以下,5名年龄在12岁及以上至18岁,这些患者至少每年就诊2次。研究了这两组患者的体征出现情况、身体症状评分和智商,以及年龄与生活质量、适应功能和行为症状标准化测量指标之间的纵向关联,这些指标由父母和孩子自我报告进行评定。计算了这些指标在患者之间和患者内部随年龄变化的斜率。

结果

除一名儿童外,所有儿童均有听力损失,大多数儿童有关节挛缩和身材矮小。躯体疾病负担随年龄增加。智商方面,虽然大多数人正常,但12岁以下儿童的智商也随年龄增长而提高。身体生活质量随年龄下降,而心理社会生活质量随年龄上升。尽管其他适应技能处于大致平均水平,但相对于标准数据,日常生活技能在基线时较低且随时间下降。行为评定显示,注意力和多动症状随时间有所改善。没有患者有严重的精神病理学问题,但年龄较大的儿童在自我报告中表示,他们越来越感到不足和自卑,这可能是由于随着时间推移,他们越来越意识到自己与同龄人之间的差异。

结论

症状较轻的MPS II患者随着年龄增长,躯体疾病负担加重,身体生活质量较差,自尊和充足感下降。心理社会生活质量、适应技能和注意力有所改善。认识到这些问题并围绕这些问题进行干预,将有利于有资源利用此类帮助来改善长期预后的症状较轻的MPS II患者。

相似文献

1
A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II.
Mol Genet Metab Rep. 2016 Apr 1;7:32-9. doi: 10.1016/j.ymgmr.2016.03.005. eCollection 2016 Jun.
3
Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.
Mol Genet Metab. 2015 Feb;114(2):170-7. doi: 10.1016/j.ymgme.2014.12.299. Epub 2014 Dec 9.
4
Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI.
Mol Genet Metab Rep. 2016 Apr 1;7:27-31. doi: 10.1016/j.ymgmr.2016.03.006. eCollection 2016 Jun.
5
The natural history of neurocognition in MPS disorders: A review.
Mol Genet Metab. 2021 May;133(1):8-34. doi: 10.1016/j.ymgme.2021.03.002. Epub 2021 Mar 11.
6
Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and Validity.
JIMD Rep. 2016;26:61-8. doi: 10.1007/8904_2015_485. Epub 2015 Aug 25.

引用本文的文献

1
Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China.
Orphanet J Rare Dis. 2024 Sep 6;19(1):324. doi: 10.1186/s13023-024-03333-4.
2
Psychobehavioral factors and family functioning in mucopolysaccharidosis: preliminary studies.
Front Public Health. 2024 Jan 24;12:1305878. doi: 10.3389/fpubh.2024.1305878. eCollection 2024.
5
Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.
Front Cardiovasc Med. 2022 Mar 7;9:839391. doi: 10.3389/fcvm.2022.839391. eCollection 2022.
6
Timing is everything: Clinical courses of Hunter syndrome associated with age at initiation of therapy in a sibling pair.
Mol Genet Metab Rep. 2022 Feb 2;30:100845. doi: 10.1016/j.ymgmr.2022.100845. eCollection 2022 Mar.
7
Innate Immunity in Mucopolysaccharide Diseases.
Int J Mol Sci. 2022 Feb 11;23(4):1999. doi: 10.3390/ijms23041999.
9
Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS).
Orphanet J Rare Dis. 2020 May 14;15(1):114. doi: 10.1186/s13023-020-01382-z.
10
The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome.
Mol Genet Metab Rep. 2019 Dec 20;22:100549. doi: 10.1016/j.ymgmr.2019.100549. eCollection 2020 Mar.

本文引用的文献

1
Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI.
Mol Genet Metab Rep. 2016 Apr 1;7:27-31. doi: 10.1016/j.ymgmr.2016.03.006. eCollection 2016 Jun.
2
Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and Validity.
JIMD Rep. 2016;26:61-8. doi: 10.1007/8904_2015_485. Epub 2015 Aug 25.
3
Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.
Mol Genet Metab. 2015 Sep-Oct;116(1-2):61-8. doi: 10.1016/j.ymgme.2015.06.002. Epub 2015 Jun 17.
4
Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.
Mol Genet Metab. 2015 Feb;114(2):170-7. doi: 10.1016/j.ymgme.2014.12.299. Epub 2014 Dec 9.
5
Health-Related Quality of Life in Patients with MPS II.
J Genet Couns. 2015 Aug;24(4):635-44. doi: 10.1007/s10897-014-9791-7. Epub 2014 Nov 14.
6
7
MPS II: adaptive behavior of patients and impact on the family system.
J Genet Couns. 2014 Jun;23(3):330-8. doi: 10.1007/s10897-013-9665-4. Epub 2013 Nov 6.
8
The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life.
Orphanet J Rare Dis. 2013 Jul 10;8:101. doi: 10.1186/1750-1172-8-101.
10
Restricted joint range of motion in patients with MPS II: correlation with height, age and functional status.
Acta Paediatr. 2012 Apr;101(4):e183-8. doi: 10.1111/j.1651-2227.2011.02522.x. Epub 2011 Dec 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验